293 related articles for article (PubMed ID: 33196577)
1. Characterizing chronic pain phenotypes in multiple sclerosis: a nationwide survey study.
Kratz AL; Whibley D; Alschuler KN; Ehde DM; Williams DA; Clauw DJ; Braley TJ
Pain; 2021 May; 162(5):1426-1433. PubMed ID: 33196577
[TBL] [Abstract][Full Text] [Related]
2. Widespread Pain With Nociplastic Features is an Independent Predictor of Low Physical Activity in People with Multiple Sclerosis.
Abou L; Whibley D; Clauw DJ; Kratz AL
J Pain; 2024 Feb; 25(2):418-427. PubMed ID: 37741524
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic and Nociplastic Pain Profiles are Common in Adult Chronic Nonbacterial Osteitis (CNO).
Leerling AT; Niesters M; Flendrie M; Tel M; Appelman-Dijkstra NM; Dekkers OM; Winter EM
Calcif Tissue Int; 2024 Jun; 114(6):603-613. PubMed ID: 38627292
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
[TBL] [Abstract][Full Text] [Related]
5. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
6. Pain Phenotypes in Adults Living With Cerebral Palsy.
Peterson MD; Haapala HJ; Kratz A
Neurol Clin Pract; 2021 Dec; 11(6):e848-e855. PubMed ID: 34992968
[TBL] [Abstract][Full Text] [Related]
7. Clinical Phenotyping for Pain Mechanisms in Urologic Chronic Pelvic Pain Syndromes: A MAPP Research Network Study.
Schrepf A; Gallop R; Naliboff B; Harte SE; Afari N; Lai HH; Pontari M; McKernan LC; Strachan E; Kreder KJ; As-Sanie SA; Rodriguez LV; Griffith JW; Williams DA;
J Pain; 2022 Sep; 23(9):1594-1603. PubMed ID: 35472518
[TBL] [Abstract][Full Text] [Related]
8. Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain.
Fernández-de-Las-Peñas C; Nijs J; Cagnie B; Gerwin RD; Plaza-Manzano G; Valera-Calero JA; Arendt-Nielsen L
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983849
[TBL] [Abstract][Full Text] [Related]
9. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
10. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
11. Characterizing cannabis use in a sample of adults with multiple sclerosis and chronic pain: An observational study.
Link K; Knowles LM; Alschuler KN; Ehde DM
Mult Scler Relat Disord; 2023 Jul; 75():104742. PubMed ID: 37156034
[TBL] [Abstract][Full Text] [Related]
12. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Approaches to Nociplastic Pain Based on Findings in the Reserpine-Induced Fibromyalgia-Like Animal Model.
Nagakura Y
J Pharmacol Exp Ther; 2022 May; 381(2):106-119. PubMed ID: 35246482
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Nociplastic Pain Involvement and Medication Use, Symptom Relief, and Adverse Effects Among People Using Medical Cannabis for Chronic Pain.
Scott JR; Williams DA; Harte SE; Harris RE; Litinas E; Sisley S; Clauw DJ; Boehnke KF
Clin J Pain; 2024 Jan; 40(1):1-9. PubMed ID: 37823303
[TBL] [Abstract][Full Text] [Related]
16. Carpal Tunnel Syndrome: Neuropathic Pain Associated or Not with a Nociplastic Condition.
Fernández-de-Las-Peñas C; Fuensalida-Novo S; Nijs J; Basson A; Plaza-Manzano G; Valera-Calero JA; Arendt-Nielsen L; de-la-Llave-Rincón AI
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371839
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults.
Wiffen PJ; Derry S; Moore RA; Kalso EA
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD005451. PubMed ID: 24719027
[TBL] [Abstract][Full Text] [Related]
18. Nociplastic Pain in Multiple Sclerosis Spasticity: Dermatomal Evaluation, Treatment with Intradermal Saline Injection and Outcomes Assessed by 3D Gait Analysis: Review and a Case Report.
De Blasiis P; de Sena G; Signoriello E; Sirico F; Imamura M; Lus G
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805532
[TBL] [Abstract][Full Text] [Related]
19. Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain.
Fitzcharles MA; Petzke F; Tölle TR; Häuser W
Drugs; 2021 Dec; 81(18):2103-2116. PubMed ID: 34800285
[TBL] [Abstract][Full Text] [Related]
20. Association Between Nociplastic Pain and Pain Severity and Impact in Women With Chronic Pelvic Pain.
Till SR; Schrepf A; Clauw DJ; Harte SE; Williams DA; As-Sanie S
J Pain; 2023 Aug; 24(8):1406-1414. PubMed ID: 36958459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]